文摘
A new series of cyclic sulfamide derivatives were synthesized and evaluated for their ability to inhibit 11尾-HSD1. Among this series, 18e showed good in vitro activity toward human 11尾-HSD1, selectivity against 11尾-HSD2, microsomal stability, and pharmacokinetic and safety profiles (hERG, CYP, and acute toxicity). Additionally, 18e exhibited good in vivo efficacy in rat and monkey models.
Keywords:
diabetes; antidiabetic agents; 11尾-hydroxysteroid dehydrogenase type 1; cyclic sulfamide; adamantyl group